ArticleDiabetes spectrum : a publication of the American Diabetes Association2025
Glucose Extremes and Cognitive Function: A Review of the Neurological Impacts of Hypoglycemia and Hyperglycemia in Type 1 Diabetes.
Article in Diabetes spectrum : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Acute glycemic variability and short-term mortality of patients with subarachnoid hemorrhage: a meta-analysis.Frontiers in neurology · 2026Pooled it
- Nutrition optimization in enhanced recovery after brain tumor surgery: scoping review of evidence, gaps, and a proposed perioperative nutrition score.Neuro-oncology advancesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article explores the neurological impacts of hypoglycemia and hyperglycemia on cognitive function in type 1 diabetes. It reviews how fluctuating glucose levels disrupt critical brain metabolic pathways, impairing various cognitive processes such as memory, attention, and executive functioning. The authors highlight both the acute and long-term effects of glycemic variability on critical brain regions, including the hippocampus, prefrontal cortex, and occipital lobes. Notably, both hyperglycemia and hypoglycemia contribute to cognitive dysfunction but through different mechanisms. Hypoglycemia induces an energy crisis in the brain, triggering increased oxidative stress and neuronal vulnerability, with repeated episodes leading to cumulative hippocampal and prefrontal damage. Hyperglycemia results in vascular compromise, disrupting cerebral blood flow and leading to various states of neurotransmitter dysregulation, with chronic exposure being associated with structural changes such as reduced gray matter volume. Diabetes technology devices such as continuous glucose monitoring systems may reduce cognitive impairments associated with glucose fluctuations, but their benefits underscore the limitations of A1C alone and the need for metrics that better capture glycemic variability. This review underscores the need to prioritize glucose control to protect cognitive health in patients with type 1 diabetes.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.